Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
DGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$146.91 - $191.49
Previous CloseN/A
Volume143.08K
Average Volume (3M)755.87K
Market Cap
$20.58B
Enterprise Value$26.48B
Total Cash (Recent Filing)$319.00M
Total Debt (Recent Filing)$6.38B
Price to Earnings (P/E)22.0
Beta0.21
Next Earnings
Oct 21, 2025EPS Estimate
2.5Last Dividend Ex-Date
Oct 03, 2025Dividend Yield1.71%
Share Statistics
EPS (TTM)2.62
Shares Outstanding111,823,440
10 Day Avg. Volume949,132
30 Day Avg. Volume755,868
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue2.52
Enterprise Value/Gross Profit7.62
Enterprise Value/Ebitda13.76
Forecast
1Y Price Target
$192.50Price Target Upside4.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceQuest Diagnostics raised its 2025 earnings guidance due to strong utilization trends and market share gains.
Revenue GrowthDGX's multi-year growth outlook calls for revenue growth, driven by a mix of volumes and tests/requisition.
Strategic PartnershipsQuest's announced JV with Corewell Health screens as a prudent use of capital and aligns with the company's overarching strategy to do more hospital outreach deals.
Bears Say
Potential HeadwindsPotential macro changes tied to eroding Medicaid/HIX volumes are seen as potential headwinds for DGX.
Regulatory ChallengesThe outlook over the near- and long-term remains intact despite potential headwinds from legislative impacts.
Quest Diagnostics News
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $146.91 and its highest was $191.49 in the past 12 months.
What is Quest Diagnostics’s market cap?
Quest Diagnostics’s market cap is $20.58B.
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Oct 21, 2025 which is in 8 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Jul 22, 2025. The company reported $2.62 earnings per share for the quarter, beating the consensus estimate of $2.57 by $0.05.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.8 which represents an annual dividend yield of 1.71%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is 2.5.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,823,440 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.62 in its last earnings report, beating expectations of $2.57. Following the earnings report the stock price went up 7.085%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Currently, no hedge funds are holding shares in DGX
Quest Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$192.50 (4.58% Upside)
$192.50 (4.58% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 2.7%
Last 30 Days ▲ 2.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.88%
12-Months-Change
Fundamentals
Return on Equity
13.65%
Trailing 12-Months
Asset Growth
15.04%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics (DGX) is a leading provider of diagnostic information services, specializing in laboratory testing and related services. The company operates a vast network of laboratories and patient service centers across the United States, offering a wide range of tests that include routine blood tests, genetic testing, and more advanced diagnostics. Quest Diagnostics serves various sectors, including healthcare providers, hospitals, and employers, and is committed to delivering accurate and timely test results that facilitate patient care and medical decision-making.
DGX Company Deck
DGX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Quest Diagnostics reported strong top-line and bottom-line growth driven by strategic acquisitions, operational improvements, and expansion in advanced diagnostics. While there were challenges related to tariffs, wage increases, and potential legislative impacts, the company managed these within its guidance and raised its full-year outlook.View all DGX earnings summariesDGX Revenue Breakdown
97.39% Diagnostic Information Services
2.61% All other operating segments
DGX Stock 12 Month Forecast
Average Price Target
$192.50
▲(4.58% Upside)
Technical Analysis
Ownership Overview
0.43% Insiders
32.75% Mutual Funds
15.45% Other Institutional Investors
23.99% Public Companies and
Individual Investors